Claudin18.2-targeted CAR-T Cells is named as a drug or biological intervention in 2 clinical trials in our China trial register, 2 of which are recruiting. Lead sponsors include Second Affiliated Hospital, Zhejiang University, School of Medicine (1) and Hainan Cancer Hospital (1). Registered phases: Phase 1 and Phase EARLY_PHASE1. Conditions studied include Colorectal Neoplasia; Advanced Pancreatic Cancer.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07416240 | Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer. (ClinicalTrials.gov ↗) Advanced Pancreatic Cancer |
Phase EARLY_PHASE1 | Recruiting |
| NCT06946615 | Exploratory Clinical Study of Claudin18.2-Targeted CAR-DC and CAR-T Therapy in Advanced Colorectal Cancer (ClinicalTrials.gov ↗) Colorectal Neoplasia |
Phase 1 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Colorectal Neoplasia | 1 |
| Advanced Pancreatic Cancer | 1 |
| Lead sponsor | Trials |
|---|---|
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Hainan Cancer Hospital | 1 |
| Register | Claudin18.2-targeted CAR-T Cells trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Claudin18.2-targeted CAR-T Cells works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Claudin18.2-targeted CAR-T Cells (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.